Even if RIO does a JV deal with Extract involving equity (newly allocated shares) RIO still has to make a formal takeover offer for Extract under the 20% rule.The 20 per cent rule means a person cannot normally acquire 20 per cent or more of a company without making a formal takeover bid.
Under the so-called "creep" provisions, a shareholder can raise their stake above 20 per cent by buying up to three per cent of the company every six months.
Furthermore, such a cap raising would dilute KAH's share of EXT to around 30%, about the same as RIO, post JV deal. Thus RIO only has to pay a premium for 21% more EXT shares to acquire EXT, whereas, CGNPC has to acquire 51% at a premium price.
If I were CGNPC I would pounce NOW via a KAH offer! However, EXT holders are likely to get more for their shares via RIO's strategic JV deal and a direct bidding war for EXT shares.
- Forums
- ASX - By Stock
- extract's husab financing talks advance
EXT
excite technology services ltd
Add to My Watchlist
11.1%
!
1.0¢

Even if RIO does a JV deal with Extract involving equity (newly...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $20.72M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.8¢ | $31.15K | 3.390M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1109800 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.009 |
6 | 1884688 | 0.008 |
6 | 5198700 | 0.007 |
4 | 2850000 | 0.006 |
2 | 1280000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 627812 | 2 |
0.011 | 4227645 | 5 |
0.012 | 1982124 | 5 |
0.013 | 53000 | 1 |
0.014 | 1000000 | 1 |
Last trade - 15.23pm 27/06/2025 (20 minute delay) ? |
Featured News
EXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online